Atypical movement disorders in antiphospholipid syndrome
Identifieur interne : 003576 ( Main/Exploration ); précédent : 003575; suivant : 003577Atypical movement disorders in antiphospholipid syndrome
Auteurs : Davide Martino [Royaume-Uni, Italie] ; Nee-Kong Chew [Royaume-Uni, Malaisie] ; Pablo Mir [Royaume-Uni, Espagne] ; Mark J. Edwards [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2006-07.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Adolescent, Antiphospholipid Syndrome (diagnosis), Antiphospholipid Syndrome (drug therapy), Antiphospholipid Syndrome (physiopathology), Antiphospholipid antibody syndrome, Brain (pathology), Brain (physiopathology), Cerebral Infarction (diagnosis), Cerebral Infarction (drug therapy), Cerebral Infarction (physiopathology), Diagnosis, Differential, Dyskinesias (diagnosis), Dyskinesias (drug therapy), Dyskinesias (physiopathology), Electroencephalography (drug effects), Electromyography (drug effects), Female, Follow-Up Studies, Frontal Lobe (pathology), Frontal Lobe (physiopathology), Humans, Lupus Erythematosus, Systemic (diagnosis), Lupus Erythematosus, Systemic (drug therapy), Lupus Erythematosus, Systemic (physiopathology), Magnetic Resonance Imaging, Middle Aged, Movement Disorders (diagnosis), Movement Disorders (drug therapy), Movement Disorders (physiopathology), Myoclonus (diagnosis), Myoclonus (drug therapy), Myoclonus (physiopathology), Nervous system diseases, Neurologic Examination (drug effects), Neuropsychological Tests, Occipital Lobe (pathology), Occipital Lobe (physiopathology), Oral administration, Phenindione (therapeutic use), Phenprocoumon (therapeutic use), Platelet, Sneddon Syndrome (diagnosis), Sneddon Syndrome (drug therapy), Sneddon Syndrome (physiopathology), Spinocerebellar Degenerations (diagnosis), Spinocerebellar Degenerations (drug therapy), Spinocerebellar Degenerations (physiopathology), Tic, Tics (diagnosis), Tics (drug therapy), Tics (physiopathology), Tourette Syndrome (diagnosis), Tourette Syndrome (drug therapy), Tourette Syndrome (physiopathology), Tremor, Tremor (diagnosis), Tremor (drug therapy), Tremor (physiopathology), Warfarin (therapeutic use), antiphospholipid syndrome, corticobasal syndrome, oral anticoagulation, tics, tremor.
- MESH :
- chemical , therapeutic use : Phenindione, Phenprocoumon, Warfarin.
- diagnosis : Antiphospholipid Syndrome, Cerebral Infarction, Dyskinesias, Lupus Erythematosus, Systemic, Movement Disorders, Myoclonus, Sneddon Syndrome, Spinocerebellar Degenerations, Tics, Tourette Syndrome, Tremor.
- drug effects : Electroencephalography, Electromyography, Neurologic Examination.
- drug therapy : Antiphospholipid Syndrome, Cerebral Infarction, Dyskinesias, Lupus Erythematosus, Systemic, Movement Disorders, Myoclonus, Sneddon Syndrome, Spinocerebellar Degenerations, Tics, Tourette Syndrome, Tremor.
- pathology : Brain, Frontal Lobe, Occipital Lobe.
- physiopathology : Antiphospholipid Syndrome, Brain, Cerebral Infarction, Dyskinesias, Frontal Lobe, Lupus Erythematosus, Systemic, Movement Disorders, Myoclonus, Occipital Lobe, Sneddon Syndrome, Spinocerebellar Degenerations, Tics, Tourette Syndrome, Tremor.
- Adolescent, Diagnosis, Differential, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging, Middle Aged, Neuropsychological Tests.
Abstract
Movement disorders have only rarely been reported in association with antiphospholipid syndrome (APS). In such cases, chorea is the most common disorder observed, with occasional reports of hemidystonia, Parkinsonism, and hemiballism. We report here on 3 cases of APS (3 women ages 16, 46, and 56 years) who presented with movement disorders, including tics, tremor, myoclonus, and a corticobasal syndrome, never or rarely reported in association with this disease. Mild executive dysfunction was observed in all 3 patients. We also report the successful treatment of two of these patients with mild oral anticoagulation (INR 2–3). Movement disorders in APS seem more clinically heterogeneous than previously thought. Oral anticoagulation should be considered in the treatment of movement disorders associated with APS. © 2006 Movement Disorder Society
Url:
DOI: 10.1002/mds.20842
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001F18
- to stream Istex, to step Curation: 001F18
- to stream Istex, to step Checkpoint: 002037
- to stream PubMed, to step Corpus: 002D33
- to stream PubMed, to step Curation: 002D33
- to stream PubMed, to step Checkpoint: 002E65
- to stream Ncbi, to step Merge: 001598
- to stream Ncbi, to step Curation: 001598
- to stream Ncbi, to step Checkpoint: 001598
- to stream Main, to step Merge: 004891
- to stream PascalFrancis, to step Corpus: 001A89
- to stream PascalFrancis, to step Curation: 001232
- to stream PascalFrancis, to step Checkpoint: 001C23
- to stream Main, to step Merge: 004D18
- to stream Main, to step Curation: 003576
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Atypical movement disorders in antiphospholipid syndrome</title>
<author><name sortKey="Martino, Davide" sort="Martino, Davide" uniqKey="Martino D" first="Davide" last="Martino">Davide Martino</name>
</author>
<author><name sortKey="Chew, Nee Ong" sort="Chew, Nee Ong" uniqKey="Chew N" first="Nee-Kong" last="Chew">Nee-Kong Chew</name>
</author>
<author><name sortKey="Mir, Pablo" sort="Mir, Pablo" uniqKey="Mir P" first="Pablo" last="Mir">Pablo Mir</name>
</author>
<author><name sortKey="Edwards, Mark J" sort="Edwards, Mark J" uniqKey="Edwards M" first="Mark J." last="Edwards">Mark J. Edwards</name>
</author>
<author><name sortKey="Quinn, Niall P" sort="Quinn, Niall P" uniqKey="Quinn N" first="Niall P." last="Quinn">Niall P. Quinn</name>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CE5912ACEC6C9DF3B6B58AEAEAD7EF4CFEE742CD</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1002/mds.20842</idno>
<idno type="url">https://api.istex.fr/document/CE5912ACEC6C9DF3B6B58AEAEAD7EF4CFEE742CD/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001F18</idno>
<idno type="wicri:Area/Istex/Curation">001F18</idno>
<idno type="wicri:Area/Istex/Checkpoint">002037</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Martino D:atypical:movement:disorders</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16538618</idno>
<idno type="wicri:Area/PubMed/Corpus">002D33</idno>
<idno type="wicri:Area/PubMed/Curation">002D33</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002E65</idno>
<idno type="wicri:Area/Ncbi/Merge">001598</idno>
<idno type="wicri:Area/Ncbi/Curation">001598</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001598</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Martino D:atypical:movement:disorders</idno>
<idno type="wicri:Area/Main/Merge">004891</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:06-0393855</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001A89</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001232</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001C23</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Martino D:atypical:movement:disorders</idno>
<idno type="wicri:Area/Main/Merge">004D18</idno>
<idno type="wicri:Area/Main/Curation">003576</idno>
<idno type="wicri:Area/Main/Exploration">003576</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Atypical movement disorders in antiphospholipid syndrome</title>
<author><name sortKey="Martino, Davide" sort="Martino, Davide" uniqKey="Martino D" first="Davide" last="Martino">Davide Martino</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological and Psychiatric Sciences, University of Bari, Bari</wicri:regionArea>
<wicri:noRegion>Bari</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chew, Nee Ong" sort="Chew, Nee Ong" uniqKey="Chew N" first="Nee-Kong" last="Chew">Nee-Kong Chew</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Malaisie</country>
<wicri:regionArea>Division of Neurology, Department of Medicine, University of Malaya, Kuala Lumpur</wicri:regionArea>
<wicri:noRegion>Kuala Lumpur</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mir, Pablo" sort="Mir, Pablo" uniqKey="Mir P" first="Pablo" last="Mir">Pablo Mir</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Servicio de Neurología, Hospital Universitario Virgen del Rocío, Seville</wicri:regionArea>
<wicri:noRegion>Seville</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Edwards, Mark J" sort="Edwards, Mark J" uniqKey="Edwards M" first="Mark J." last="Edwards">Mark J. Edwards</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Quinn, Niall P" sort="Quinn, Niall P" uniqKey="Quinn N" first="Niall P." last="Quinn">Niall P. Quinn</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2006-07">2006-07</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="944">944</biblScope>
<biblScope unit="page" to="949">949</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">CE5912ACEC6C9DF3B6B58AEAEAD7EF4CFEE742CD</idno>
<idno type="DOI">10.1002/mds.20842</idno>
<idno type="ArticleID">MDS20842</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Antiphospholipid Syndrome (diagnosis)</term>
<term>Antiphospholipid Syndrome (drug therapy)</term>
<term>Antiphospholipid Syndrome (physiopathology)</term>
<term>Antiphospholipid antibody syndrome</term>
<term>Brain (pathology)</term>
<term>Brain (physiopathology)</term>
<term>Cerebral Infarction (diagnosis)</term>
<term>Cerebral Infarction (drug therapy)</term>
<term>Cerebral Infarction (physiopathology)</term>
<term>Diagnosis, Differential</term>
<term>Dyskinesias (diagnosis)</term>
<term>Dyskinesias (drug therapy)</term>
<term>Dyskinesias (physiopathology)</term>
<term>Electroencephalography (drug effects)</term>
<term>Electromyography (drug effects)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Frontal Lobe (pathology)</term>
<term>Frontal Lobe (physiopathology)</term>
<term>Humans</term>
<term>Lupus Erythematosus, Systemic (diagnosis)</term>
<term>Lupus Erythematosus, Systemic (drug therapy)</term>
<term>Lupus Erythematosus, Systemic (physiopathology)</term>
<term>Magnetic Resonance Imaging</term>
<term>Middle Aged</term>
<term>Movement Disorders (diagnosis)</term>
<term>Movement Disorders (drug therapy)</term>
<term>Movement Disorders (physiopathology)</term>
<term>Myoclonus (diagnosis)</term>
<term>Myoclonus (drug therapy)</term>
<term>Myoclonus (physiopathology)</term>
<term>Nervous system diseases</term>
<term>Neurologic Examination (drug effects)</term>
<term>Neuropsychological Tests</term>
<term>Occipital Lobe (pathology)</term>
<term>Occipital Lobe (physiopathology)</term>
<term>Oral administration</term>
<term>Phenindione (therapeutic use)</term>
<term>Phenprocoumon (therapeutic use)</term>
<term>Platelet</term>
<term>Sneddon Syndrome (diagnosis)</term>
<term>Sneddon Syndrome (drug therapy)</term>
<term>Sneddon Syndrome (physiopathology)</term>
<term>Spinocerebellar Degenerations (diagnosis)</term>
<term>Spinocerebellar Degenerations (drug therapy)</term>
<term>Spinocerebellar Degenerations (physiopathology)</term>
<term>Tic</term>
<term>Tics (diagnosis)</term>
<term>Tics (drug therapy)</term>
<term>Tics (physiopathology)</term>
<term>Tourette Syndrome (diagnosis)</term>
<term>Tourette Syndrome (drug therapy)</term>
<term>Tourette Syndrome (physiopathology)</term>
<term>Tremor</term>
<term>Tremor (diagnosis)</term>
<term>Tremor (drug therapy)</term>
<term>Tremor (physiopathology)</term>
<term>Warfarin (therapeutic use)</term>
<term>antiphospholipid syndrome</term>
<term>corticobasal syndrome</term>
<term>oral anticoagulation</term>
<term>tics</term>
<term>tremor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Phenindione</term>
<term>Phenprocoumon</term>
<term>Warfarin</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Antiphospholipid Syndrome</term>
<term>Cerebral Infarction</term>
<term>Dyskinesias</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Movement Disorders</term>
<term>Myoclonus</term>
<term>Sneddon Syndrome</term>
<term>Spinocerebellar Degenerations</term>
<term>Tics</term>
<term>Tourette Syndrome</term>
<term>Tremor</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Electroencephalography</term>
<term>Electromyography</term>
<term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Antiphospholipid Syndrome</term>
<term>Cerebral Infarction</term>
<term>Dyskinesias</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Movement Disorders</term>
<term>Myoclonus</term>
<term>Sneddon Syndrome</term>
<term>Spinocerebellar Degenerations</term>
<term>Tics</term>
<term>Tourette Syndrome</term>
<term>Tremor</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term>
<term>Frontal Lobe</term>
<term>Occipital Lobe</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Antiphospholipid Syndrome</term>
<term>Brain</term>
<term>Cerebral Infarction</term>
<term>Dyskinesias</term>
<term>Frontal Lobe</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Movement Disorders</term>
<term>Myoclonus</term>
<term>Occipital Lobe</term>
<term>Sneddon Syndrome</term>
<term>Spinocerebellar Degenerations</term>
<term>Tics</term>
<term>Tourette Syndrome</term>
<term>Tremor</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Middle Aged</term>
<term>Neuropsychological Tests</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antiphospholipide syndrome</term>
<term>Système nerveux pathologie</term>
<term>Thrombocyte</term>
<term>Tic</term>
<term>Tremblement</term>
<term>Voie orale</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Movement disorders have only rarely been reported in association with antiphospholipid syndrome (APS). In such cases, chorea is the most common disorder observed, with occasional reports of hemidystonia, Parkinsonism, and hemiballism. We report here on 3 cases of APS (3 women ages 16, 46, and 56 years) who presented with movement disorders, including tics, tremor, myoclonus, and a corticobasal syndrome, never or rarely reported in association with this disease. Mild executive dysfunction was observed in all 3 patients. We also report the successful treatment of two of these patients with mild oral anticoagulation (INR 2–3). Movement disorders in APS seem more clinically heterogeneous than previously thought. Oral anticoagulation should be considered in the treatment of movement disorders associated with APS. © 2006 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Espagne</li>
<li>Italie</li>
<li>Malaisie</li>
<li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Martino, Davide" sort="Martino, Davide" uniqKey="Martino D" first="Davide" last="Martino">Davide Martino</name>
</region>
<name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
<name sortKey="Chew, Nee Ong" sort="Chew, Nee Ong" uniqKey="Chew N" first="Nee-Kong" last="Chew">Nee-Kong Chew</name>
<name sortKey="Edwards, Mark J" sort="Edwards, Mark J" uniqKey="Edwards M" first="Mark J." last="Edwards">Mark J. Edwards</name>
<name sortKey="Mir, Pablo" sort="Mir, Pablo" uniqKey="Mir P" first="Pablo" last="Mir">Pablo Mir</name>
<name sortKey="Quinn, Niall P" sort="Quinn, Niall P" uniqKey="Quinn N" first="Niall P." last="Quinn">Niall P. Quinn</name>
</country>
<country name="Italie"><noRegion><name sortKey="Martino, Davide" sort="Martino, Davide" uniqKey="Martino D" first="Davide" last="Martino">Davide Martino</name>
</noRegion>
</country>
<country name="Malaisie"><noRegion><name sortKey="Chew, Nee Ong" sort="Chew, Nee Ong" uniqKey="Chew N" first="Nee-Kong" last="Chew">Nee-Kong Chew</name>
</noRegion>
</country>
<country name="Espagne"><noRegion><name sortKey="Mir, Pablo" sort="Mir, Pablo" uniqKey="Mir P" first="Pablo" last="Mir">Pablo Mir</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003576 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003576 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:CE5912ACEC6C9DF3B6B58AEAEAD7EF4CFEE742CD |texte= Atypical movement disorders in antiphospholipid syndrome }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |